Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 16,566	$ 31,825	$ 39,463	$ 65,601
General and administrative	4,710	7,073	11,525	14,356
Total operating expenses	21,276	38,898	50,988	79,957
Loss from operations	(21,276)	(38,898)	(50,988)	(79,957)
Interest and other income, net	536	1,622	986	3,620
Net and comprehensive loss	$ (20,740)	$ (37,276)	$ (50,002)	$ (76,337)
Net loss per common share, basic	$ (0.51)	$ (1.03)	$ (1.29)	$ (2.12)
Net loss per common share, diluted	$ (0.51)	$ (1.03)	$ (1.29)	$ (2.12)
Weighted-average number of common shares used to compute basic net loss per common share	40,630,403	36,043,561	38,639,834	35,966,965
Weighted-average number of common shares used to compute diluted net loss per common share	40,630,403	36,043,561	38,639,834	35,966,965